Literature DB >> 12065896

Characterization of bradykinin receptors in canine cultured corneal epithelial cells: pharmacological and functional studies.

Samuel C M Huang1, Li-Der Hsiao, Chin-Sung Chien, Chuan-Chwan Wang, Chi-Tso Chiu, Ray J F Tsai, Chuen-Mao Yang.   

Abstract

The pharmacological properties of bradykinin (BK) receptors were characterized in canine cultured corneal epithelial cells (CECs) using [(3)H]-BK as a radioligand. Analysis of binding isotherms gave an apparent equilibrium dissociation constant of 0.34 +/- 0.07 nM and a maximum receptor density of 179 +/- 23 fmol/mg protein. Neither a B(1) receptor-selective agonist (des-Arg(9)-BK) nor antagonist ([Leu(8), des-Arg(9)]-BK) significantly inhibited [(3)H]-BK binding to CECs, thus excluding the presence of B(1) receptors in canine CECs. The specific binding of [(3)H]-BK to CECs was inhibited by B(2) receptor-selective agonists (BK and kallidin) and antagonists (Hoe 140 and [D-Arg(0), Hyp(3), Thi(5,8), D-Phe(7)]-BK), with a best fit using a one-binding-site model. The order of potency for the inhibition of [(3)H]-BK binding was BK = Hoe 140 > kallidin > [D-Arg(0), Hyp(3), Thi(5,8), D-Phe(7)]-BK. Stimulation of CECs by BK produced a concentration-dependent accumulation of inositol phosphates (IP) and an initial transient peak of intracellular Ca(2+). B(2) receptor-selective antagonist ([D-Arg(0), Hyp(3), Thi(5,8), D-Phe(7)]-BK) significantly antagonized the BK-induced responses with dissociation constants of 6.0-6.1. Pretreatment of CECs with pertussis toxin (PTX) or cholera toxin did not alter the BK-induced IP accumulation. Incubation of CECs in the absence of external Ca(2+) led to a significant attenuation of the IP accumulation induced by BK. These results demonstrate that BK directly stimulates phospholipase C-mediated signal transduction through BK B(2) receptors via a PTX-insensitive G protein in canine CECs. This effect may function as the transducing mechanism for BK-mediated cellular responses. Copyright 2002 National Science Council, ROC and S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12065896     DOI: 10.1007/bf02256068

Source DB:  PubMed          Journal:  J Biomed Sci        ISSN: 1021-7770            Impact factor:   8.410


  3 in total

1.  Bradykinin-stimulated cyclooxygenase activity stimulates vas deferens epithelial anion secretion in vitro in swine and humans.

Authors:  Fernando Pierucci-Alves; Bruce D Schultz
Journal:  Biol Reprod       Date:  2008-05-14       Impact factor: 4.285

2.  Pharmacological characterization of canine bradykinin receptors in prostatic culture and in isolated prostate.

Authors:  Dinesh Srinivasan; Leah R Burbach; Donald V Daniels; Anthony P D W Ford; Anindya Bhattacharya
Journal:  Br J Pharmacol       Date:  2004-05       Impact factor: 8.739

3.  Bradykinin regulates cell growth and migration in cultured human cardiac c-Kit+ progenitor cells.

Authors:  Gang Li; Yan Wang; Gui-Rong Li
Journal:  Oncotarget       Date:  2017-02-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.